Abstract:Abstract Background Cystic fibrosis (CF) is a chronic multisystem disease with features including recurrent pulmonary infection, bronchiectasis, malnutrition, and alterations in drug metabolism which may discourage referral and listing for kidney transplantation. Although no specific renal phenotype is identified in CF, chronic kidney disease (CKD) occurs in young people and adults with CF with greater frequency than in the general population. The characteristics and outcomes of kidney transplantation in the CF population have not been previously described. Methods We used de-identified data supplied by the US Renal Data System (USRDS) to compare persons with end stage kidney disease (ESKD) with first kidney transplant, who did and did not have a diagnosis of CF. We compared demographic and clinical characteristics, mortality, patient survival, and death-censored graft survival using linear and logistic regression, multivariable logistic regression models, and Kaplan-Meier and log-rank tests with stratification/binning by propensity scores. Results Of those with dual diagnoses of CF and ESKD, half received a first kidney transplant. CF was independently associated with higher odds of receiving a living donor transplant. Those with a kidney transplant were younger than both those who did not have CF and those with CF without transplant and had higher odds of being female. Those with dual diagnoses of CF and ESKD had disproportionately lower odds of being identified as Black or African American relative to their representation in the population of all with CF and ESKD. Diabetes was more frequently a diagnosis and primary cause of ESKD in people with CF, but was approximately half as frequently the primary cause of ESKD as in those without CF. Complications of transplantation, particularly lung, were the second most frequent etiology of ESKD in people with CF. Overall survival with ESKD was 21.1 years for those with CF and 31.8 for those without CF. The survival benefit associated with transplant was 17.2 years for those with CF and 24.8 years for those without CF. Death censored median graft survival was significantly longer for those with CF, 20.4 vs 13.7 years. Conclusions CF is a chronic multisystem disease with features which may discourage referral and listing for kidney transplant. We used de-identified data from the USRDS datasets to describe the characteristics and outcomes of all unique individuals with the diagnosis of CF and first kidney transplant prevalent during the five-year period 2014 and 2018. Those with CF had similar odds to those without CF or receiving a first kidney transplant, and higher odds of receiving a living donor graft. Diabetes mellitus was significantly less frequently the primary cause of ESKD in those with CF and kidney transplant. Complications of solid organ transplant, particularly lung, were the second most frequent cause of ESKD in people with CF and kidney transplant. Median patient survival following the first kidney transplant was significantly shorter than for those who did not have CF, but was substantial, as was the survival advantage when compared to dialysis. Median graft survival was significantly longer for those with CF. It is our hope that this data will improve awareness of kidney disease in persons living with CF and their care teams, and encourage early referral to nephrology and transplant centers, and positive consideration of wait listing for kidney transplantation.

Evaluation of Post‐Transfer Clinical Status of Cystic Fibrosis Patients Transferred to Adult Chest Diseases Clinic

[Self-care capacity of adult cystic fibrosis patients during transition/transfer between services]

Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States

Initial attendance and retention in adult healthcare as criteria for transition success among organ transplant recipients

Health-related quality of life of young people with long-term illnesses before and after transfer from child to adult healthcare

Cystic fibrosis transition from paediatric to adult care: international survey results

An aging population of patients with cystic fibrosis undergoes lung transplantation: An analysis of the ISHLT Thoracic Transplant Registry

[Transition from pediatric to adult care in chronic respiratory diseases: The cystic fibrosis model]

Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams

Health Care Use During Transfer to Adult Care Among Youth With Chronic Conditions

Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition

Transition from Paediatric to Adult Care in CAH: 20 Years of Experience at a Tertiary Referral Center

Planned Transition of Adolescent Patients with Inflammatory Bowel Disease Results in Higher Remission Rates

Measurable Outcomes After Transfer From Pediatric to Adult Providers in Youth With Chronic Illness

A novel transition clinic structure for adolescent and young adult patients with childhood onset rheumatic disease improves transition outcomes

Transition to adult care: experiences and expectations of adolescents with a chronic illness

Outcomes of Kidney Transplantation in Cystic Fibrosis

The transition process for paediatric rheumatology clinic patients at a single tertiary paediatric rheumatology centre in Australia

Healthcare transition for adolescents and young adults with long-term conditions: Qualitative study of patients, parents and healthcare professionals' experiences

Impact of CF summer camp

Gaps during Pediatric to Adult Care Transfer Escalate Acute Resource Utilization in Sickle Cell Disease